April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Extra-cellular Adenosine Pathway In Trabecular Meshwork Cells
Author Affiliations & Notes
  • Jing Wu
    Duke Eye Center, Durham, North Carolina
  • Guorong Li
    Duke Eye Center, Durham, North Carolina
  • Carolia Luna
    Duke Eye Center, Durham, North Carolina
  • David L. Epstein
    Department of Ophthalmology,
    Duke Eye Center, Durham, North Carolina
  • Pedro Gonzalez
    Ophthalmology, Duke Eye Center, Duke University, Durham, North Carolina
  • Footnotes
    Commercial Relationships  Jing Wu, None; Guorong Li, None; Carolia Luna, None; David L. Epstein, None; Pedro Gonzalez, None
  • Footnotes
    Support  NEI EY016228, NEI EY01894, NEI EY019137, NEI EY05722, Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4637. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jing Wu, Guorong Li, Carolia Luna, David L. Epstein, Pedro Gonzalez; Extra-cellular Adenosine Pathway In Trabecular Meshwork Cells. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4637.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Activation of adenosine (ADO) receptors has been shown to exert important effects on aqueous humor outflow facility. Currently, specific A1 receptor agonists are being tested as potential therapeutic agents for glaucoma treatment. We investigated the presence of mechanisms for endogenous production of extracellular ADO in the outflow pathway and the potential role of adenosine in the regulation of contraction in trabecular meshwork cells.

Methods: : Porcine trabecular meshwork (PTM) cells incubated with ATP (15 uM), cAMP (15 uM), or control vehicle were treated with specific inhibitors for ecto-5’-phosphodiesterase (IBMX, 10 mM) or ecto-5’-nucleotidase (AMPCP, 10 mM). Extra-cellular levels of ADO production were evaluated by HPLC. Effects of specific ADO receptor agonists (CPA, CGS-21680, IB-MECA, 20uM) on cell contraction were measured using a three-dimensional collagen gel (1.5 mg/mL COLA1A) contraction assay.

Results: : PTM cells produced extra-cellular ADO at a rate that was independent from the extra-cellular concentrations of cAMP or ATP (ecto-5’-phosphodiesterase substrates), and was not affected by inhibition of ecto-5’-phosphodiesterase activity by IBMX. However, inhibition of ecto-5’-nucleotidase activity with AMPCP resulted in a decrease of more than 60% in ADO formation. Serum-induced cell contraction was increased in the presence of adenosine or the specific A1 receptor agonist CPA (37%, SD= 7, p=0.02) and decreased by agonists for the A2, CGS-21680, (58%, SD=12, p=0.05).and A3, IB-MECA, (94%, SD=32, p=0.01) receptors.

Conclusions: : TM cells express an extra-cellular ADO pathway that is dependent on Ecto-5’-nucleotidase conversion of AMP into ADO. We hypothesize that endogenous production of extra-cellular adenosine contributes to the regulation of aqueous humor outflow resistance not only through induction of matrix metalloproteinases, but also by affecting the acto-myosin cytoskeleton of TM cells. A better understanding of the role played by this pathway in the outflow pathway should be useful for the development of glaucoma therapies based on adenosine receptor agonist

Keywords: adenosine • trabecular meshwork • outflow: trabecular meshwork 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.